CND2_HUMAN - dbPTM
CND2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CND2_HUMAN
UniProt AC Q15003
Protein Name Condensin complex subunit 2
Gene Name NCAPH
Organism Homo sapiens (Human).
Sequence Length 741
Subcellular Localization Nucleus . Cytoplasm . Chromosome . In interphase cells, the majority of the condensin complex is found in the cytoplasm, while a minority of the complex is associated with chromatin. A subpopulation of the complex however remains associated with chro
Protein Description Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases..
Protein Sequence MGPPGPALPATMNNSSSETRGHPHSASSPSERVFPMPLPRKAPLNIPGTPVLEDFPQNDDEKERLQRRRSRVFDLQFSTDSPRLLASPSSRSIDISATIPKFTNTQITEHYSTCIKLSTENKITTKNAFGLHLIDFMSEILKQKDTEPTNFKVAAGTLDASTKIYAVRVDAVHADVYRVLGGLGKDAPSLEEVEGHVADGSATEMGTTKKAVKPKKKHLHRTIEQNINNLNVSEADRKCEIDPMFQKTAASFDECSTAGVFLSTLHCQDYRSELLFPSDVQTLSTGEPLELPELGCVEMTDLKAPLQQCAEDRQICPSLAGFQFTQWDSETHNESVSALVDKFKKNDQVFDINAEVDESDCGDFPDGSLGDDFDANDEPDHTAVGDHEEFRSWKEPCQVQSCQEEMISLGDGDIRTMCPLLSMKPGEYSYFSPRTMSMWAGPDHWRFRPRRKQDAPSQSENKKKSTKKDFEIDFEDDIDFDVYFRKTKAATILTKSTLENQNWRATTLPTDFNYNVDTLVQLHLKPGTRLLKMAQGHRVETEHYEEIEDYDYNNPNDTSNFCPGLQAADSDDEDLDDLFVGPVGNSDLSPYPCHPPKTAQQNGDTPEAQGLDITTYGESNLVAEPQKVNKIEIHYAKTAKKMDMKKLKQSMWSLLTALSGKEADAEANHREAGKEAALAEVADEKMLSGLTKDLQRSLPPVMAQNLSIPLAFACLLHLANEKNLKLEGTEDLSDVLVRQGD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8UbiquitinationMGPPGPALPATMNNS
CCCCCCCCCCCCCCC
3.14-
11PhosphorylationPGPALPATMNNSSSE
CCCCCCCCCCCCCCC
20.6323663014
12SulfoxidationGPALPATMNNSSSET
CCCCCCCCCCCCCCC
4.9221406390
15PhosphorylationLPATMNNSSSETRGH
CCCCCCCCCCCCCCC
30.1825159151
16UbiquitinationPATMNNSSSETRGHP
CCCCCCCCCCCCCCC
34.03-
16PhosphorylationPATMNNSSSETRGHP
CCCCCCCCCCCCCCC
34.0325159151
17PhosphorylationATMNNSSSETRGHPH
CCCCCCCCCCCCCCC
42.6925159151
19PhosphorylationMNNSSSETRGHPHSA
CCCCCCCCCCCCCCC
43.8523663014
20MethylationNNSSSETRGHPHSAS
CCCCCCCCCCCCCCC
37.05115484557
25PhosphorylationETRGHPHSASSPSER
CCCCCCCCCCCCCCC
34.0126055452
27UbiquitinationRGHPHSASSPSERVF
CCCCCCCCCCCCCCC
45.88-
27PhosphorylationRGHPHSASSPSERVF
CCCCCCCCCCCCCCC
45.8825159151
28PhosphorylationGHPHSASSPSERVFP
CCCCCCCCCCCCCCC
31.9630278072
30PhosphorylationPHSASSPSERVFPMP
CCCCCCCCCCCCCCC
39.7326329039
32MethylationSASSPSERVFPMPLP
CCCCCCCCCCCCCCC
39.45115484551
41UbiquitinationFPMPLPRKAPLNIPG
CCCCCCCCCCCCCCC
53.0321890473
49UbiquitinationAPLNIPGTPVLEDFP
CCCCCCCCCCCCCCC
12.60-
49PhosphorylationAPLNIPGTPVLEDFP
CCCCCCCCCCCCCCC
12.6029255136
62UbiquitinationFPQNDDEKERLQRRR
CCCCHHHHHHHHHHH
55.94-
70PhosphorylationERLQRRRSRVFDLQF
HHHHHHHHHHHEEEC
30.8630266825
74UbiquitinationRRRSRVFDLQFSTDS
HHHHHHHEEECCCCC
36.38-
78PhosphorylationRVFDLQFSTDSPRLL
HHHEEECCCCCCCEE
20.5330266825
79PhosphorylationVFDLQFSTDSPRLLA
HHEEECCCCCCCEEC
41.6130266825
81PhosphorylationDLQFSTDSPRLLASP
EEECCCCCCCEECCC
16.4125159151
87PhosphorylationDSPRLLASPSSRSID
CCCCEECCCCCCCCE
25.8622167270
89PhosphorylationPRLLASPSSRSIDIS
CCEECCCCCCCCEEE
35.5730266825
90PhosphorylationRLLASPSSRSIDISA
CEECCCCCCCCEEEE
33.1730266825
92PhosphorylationLASPSSRSIDISATI
ECCCCCCCCEEEEEC
26.9330266825
96PhosphorylationSSRSIDISATIPKFT
CCCCCEEEEECCCCC
18.6630266825
98PhosphorylationRSIDISATIPKFTNT
CCCEEEEECCCCCCC
30.9030266825
102UbiquitinationISATIPKFTNTQITE
EEEECCCCCCCCCCC
5.52-
103PhosphorylationSATIPKFTNTQITEH
EEECCCCCCCCCCCC
43.4128555341
111PhosphorylationNTQITEHYSTCIKLS
CCCCCCCHHHEEECC
10.23-
122UbiquitinationIKLSTENKITTKNAF
EECCCCCCCCCCCHH
34.89-
126UbiquitinationTENKITTKNAFGLHL
CCCCCCCCCHHHHHH
37.3121906983
138PhosphorylationLHLIDFMSEILKQKD
HHHHHHHHHHHHCCC
22.8327174698
142UbiquitinationDFMSEILKQKDTEPT
HHHHHHHHCCCCCCC
62.0521906983
144AcetylationMSEILKQKDTEPTNF
HHHHHHCCCCCCCCC
66.1025953088
144UbiquitinationMSEILKQKDTEPTNF
HHHHHHCCCCCCCCC
66.10-
146PhosphorylationEILKQKDTEPTNFKV
HHHHCCCCCCCCCEE
51.4024719451
149PhosphorylationKQKDTEPTNFKVAAG
HCCCCCCCCCEEEEE
47.2427174698
152AcetylationDTEPTNFKVAAGTLD
CCCCCCCEEEEEECC
32.7925953088
152MethylationDTEPTNFKVAAGTLD
CCCCCCCEEEEEECC
32.7924791763
152UbiquitinationDTEPTNFKVAAGTLD
CCCCCCCEEEEEECC
32.79-
157PhosphorylationNFKVAAGTLDASTKI
CCEEEEEECCCCCCE
19.4227174698
161PhosphorylationAAGTLDASTKIYAVR
EEEECCCCCCEEEEE
29.8725159151
162PhosphorylationAGTLDASTKIYAVRV
EEECCCCCCEEEEEE
24.1525159151
163UbiquitinationGTLDASTKIYAVRVD
EECCCCCCEEEEEEC
31.09-
165PhosphorylationLDASTKIYAVRVDAV
CCCCCCEEEEEECCC
10.70-
177PhosphorylationDAVHADVYRVLGGLG
CCCCHHHHHHHCCCC
8.7828674419
185AcetylationRVLGGLGKDAPSLEE
HHHCCCCCCCCCHHH
56.6226051181
185UbiquitinationRVLGGLGKDAPSLEE
HHHCCCCCCCCCHHH
56.62-
189PhosphorylationGLGKDAPSLEEVEGH
CCCCCCCCHHHCCCC
50.5721712546
201PhosphorylationEGHVADGSATEMGTT
CCCCCCCCCCCCCCC
32.3422167270
203PhosphorylationHVADGSATEMGTTKK
CCCCCCCCCCCCCCC
28.3530266825
207PhosphorylationGSATEMGTTKKAVKP
CCCCCCCCCCCCCCC
33.8530266825
208PhosphorylationSATEMGTTKKAVKPK
CCCCCCCCCCCCCCC
25.4830266825
209AcetylationATEMGTTKKAVKPKK
CCCCCCCCCCCCCCH
38.2826051181
210UbiquitinationTEMGTTKKAVKPKKK
CCCCCCCCCCCCCHH
57.21-
222PhosphorylationKKKHLHRTIEQNINN
CHHHHHHHHHHHHHH
20.3723186163
233PhosphorylationNINNLNVSEADRKCE
HHHHCCHHHHHHHCC
26.4525159151
238UbiquitinationNVSEADRKCEIDPMF
CHHHHHHHCCCCHHH
36.45-
258UbiquitinationSFDECSTAGVFLSTL
CHHHHHCHHHHHHHC
8.89-
288UbiquitinationQTLSTGEPLELPELG
EECCCCCCCCCCCCC
32.26-
325PhosphorylationSLAGFQFTQWDSETH
HHCCCEEEECCCCCC
20.2628122231
329PhosphorylationFQFTQWDSETHNESV
CEEEECCCCCCCHHH
41.2420068231
331PhosphorylationFTQWDSETHNESVSA
EEECCCCCCCHHHHH
33.6728122231
335PhosphorylationDSETHNESVSALVDK
CCCCCCHHHHHHHHH
27.0420068231
337PhosphorylationETHNESVSALVDKFK
CCCCHHHHHHHHHHH
25.7620068231
352UbiquitinationKNDQVFDINAEVDES
HCCEEEEECCEECHH
3.41-
359UbiquitinationINAEVDESDCGDFPD
ECCEECHHHCCCCCC
33.4621890473
359PhosphorylationINAEVDESDCGDFPD
ECCEECHHHCCCCCC
33.4630576142
368PhosphorylationCGDFPDGSLGDDFDA
CCCCCCCCCCCCCCC
36.2422468782
394UbiquitinationHEEFRSWKEPCQVQS
HHHHHHCCCCCCCCC
53.69-
396UbiquitinationEFRSWKEPCQVQSCQ
HHHHCCCCCCCCCCC
15.32-
401PhosphorylationKEPCQVQSCQEEMIS
CCCCCCCCCCHHHHH
20.9330576142
408PhosphorylationSCQEEMISLGDGDIR
CCCHHHHHCCCCCHH
25.6225159151
422PhosphorylationRTMCPLLSMKPGEYS
HHHHHHHCCCCCCCC
32.2321945579
424UbiquitinationMCPLLSMKPGEYSYF
HHHHHCCCCCCCCEE
46.63-
428PhosphorylationLSMKPGEYSYFSPRT
HCCCCCCCCEECCCC
18.0021945579
429PhosphorylationSMKPGEYSYFSPRTM
CCCCCCCCEECCCCC
18.5221945579
430PhosphorylationMKPGEYSYFSPRTMS
CCCCCCCEECCCCCC
13.7421945579
432PhosphorylationPGEYSYFSPRTMSMW
CCCCCEECCCCCCCC
12.7719664994
435PhosphorylationYSYFSPRTMSMWAGP
CCEECCCCCCCCCCC
19.5826074081
457PhosphorylationRRKQDAPSQSENKKK
CCCCCCCCCCCCCCC
48.3220068231
459PhosphorylationKQDAPSQSENKKKST
CCCCCCCCCCCCCCC
47.6920068231
465PhosphorylationQSENKKKSTKKDFEI
CCCCCCCCCCCCCEE
55.1026670566
466PhosphorylationSENKKKSTKKDFEID
CCCCCCCCCCCCEEC
51.5026670566
488SumoylationDVYFRKTKAATILTK
EEEEECCCEEEEEEH
38.7728112733
488UbiquitinationDVYFRKTKAATILTK
EEEEECCCEEEEEEH
38.77-
491PhosphorylationFRKTKAATILTKSTL
EECCCEEEEEEHHHH
22.7523186163
494AcetylationTKAATILTKSTLENQ
CCEEEEEEHHHHCCC
21.06-
494PhosphorylationTKAATILTKSTLENQ
CCEEEEEEHHHHCCC
21.0623186163
495UbiquitinationKAATILTKSTLENQN
CEEEEEEHHHHCCCC
37.6921890473
496PhosphorylationAATILTKSTLENQNW
EEEEEEHHHHCCCCC
32.7525159151
497PhosphorylationATILTKSTLENQNWR
EEEEEHHHHCCCCCE
39.3820068231
501AcetylationTKSTLENQNWRATTL
EHHHHCCCCCEEEEC
41.30-
501UbiquitinationTKSTLENQNWRATTL
EHHHHCCCCCEEEEC
41.30-
501AcetylationTKSTLENQNWRATTL
EHHHHCCCCCEEEEC
41.3019608861
504UbiquitinationTLENQNWRATTLPTD
HHCCCCCEEEECCCC
29.61-
506PhosphorylationENQNWRATTLPTDFN
CCCCCEEEECCCCCC
21.9426074081
507PhosphorylationNQNWRATTLPTDFNY
CCCCEEEECCCCCCC
29.7426074081
510PhosphorylationWRATTLPTDFNYNVD
CEEEECCCCCCCCHH
57.2326074081
512UbiquitinationATTLPTDFNYNVDTL
EEECCCCCCCCHHHE
13.22-
514PhosphorylationTLPTDFNYNVDTLVQ
ECCCCCCCCHHHEEE
19.29-
532UbiquitinationKPGTRLLKMAQGHRV
CCCCHHHHHHCCCCC
36.46-
538AcetylationLKMAQGHRVETEHYE
HHHHCCCCCCCCCCH
34.49-
538UbiquitinationLKMAQGHRVETEHYE
HHHHCCCCCCCCCCH
34.49-
549UbiquitinationEHYEEIEDYDYNNPN
CCCHHHHCCCCCCCC
47.46-
556AcetylationDYDYNNPNDTSNFCP
CCCCCCCCCCCCCCC
68.28-
570PhosphorylationPGLQAADSDDEDLDD
CCCCCCCCCCCCHHH
42.0829496963
586PhosphorylationFVGPVGNSDLSPYPC
CCCCCCCCCCCCCCC
33.7226074081
589UbiquitinationPVGNSDLSPYPCHPP
CCCCCCCCCCCCCCC
27.64-
589PhosphorylationPVGNSDLSPYPCHPP
CCCCCCCCCCCCCCC
27.6426074081
591PhosphorylationGNSDLSPYPCHPPKT
CCCCCCCCCCCCCCC
18.3426074081
598PhosphorylationYPCHPPKTAQQNGDT
CCCCCCCCHHHCCCC
35.1630266825
605PhosphorylationTAQQNGDTPEAQGLD
CHHHCCCCCCCCCCE
25.1530266825
614PhosphorylationEAQGLDITTYGESNL
CCCCCEEEEECCCCC
17.4030266825
615PhosphorylationAQGLDITTYGESNLV
CCCCEEEEECCCCCE
29.8430266825
616PhosphorylationQGLDITTYGESNLVA
CCCEEEEECCCCCEE
15.3930266825
619PhosphorylationDITTYGESNLVAEPQ
EEEEECCCCCEECCC
30.9730266825
626AcetylationSNLVAEPQKVNKIEI
CCCEECCCEECEEEE
54.5619608861
630AcetylationAEPQKVNKIEIHYAK
ECCCEECEEEEEEHH
44.7123236377
630UbiquitinationAEPQKVNKIEIHYAK
ECCCEECEEEEEEHH
44.71-
635PhosphorylationVNKIEIHYAKTAKKM
ECEEEEEEHHHCCCC
18.5623917254
637AcetylationKIEIHYAKTAKKMDM
EEEEEEHHHCCCCCH
41.6819608861
637UbiquitinationKIEIHYAKTAKKMDM
EEEEEEHHHCCCCCH
41.6819608861
640UbiquitinationIHYAKTAKKMDMKKL
EEEHHHCCCCCHHHH
54.59-
648UbiquitinationKMDMKKLKQSMWSLL
CCCHHHHHHHHHHHH
49.56-
650PhosphorylationDMKKLKQSMWSLLTA
CHHHHHHHHHHHHHH
22.1920068231
653PhosphorylationKLKQSMWSLLTALSG
HHHHHHHHHHHHHHC
12.5920068231
656PhosphorylationQSMWSLLTALSGKEA
HHHHHHHHHHHCCHH
30.7420068231
659PhosphorylationWSLLTALSGKEADAE
HHHHHHHHCCHHHHH
45.4120068231
661UbiquitinationLLTALSGKEADAEAN
HHHHHHCCHHHHHHH
46.48-
674AcetylationANHREAGKEAALAEV
HHHHHHHHHHHHHHH
51.7523236377
674UbiquitinationANHREAGKEAALAEV
HHHHHHHHHHHHHHH
51.75-
685UbiquitinationLAEVADEKMLSGLTK
HHHHCCHHHHHCCCH
45.76-
692AcetylationKMLSGLTKDLQRSLP
HHHHCCCHHHHHHCC
62.5822424773
692UbiquitinationKMLSGLTKDLQRSLP
HHHHCCCHHHHHHCC
62.58-
725SumoylationLANEKNLKLEGTEDL
HHCCCCCCCCCCCCH
54.61-
725SumoylationLANEKNLKLEGTEDL
HHCCCCCCCCCCCCH
54.61-
725UbiquitinationLANEKNLKLEGTEDL
HHCCCCCCCCCCCCH
54.61-
729PhosphorylationKNLKLEGTEDLSDVL
CCCCCCCCCCHHHHH
19.5621406692
733PhosphorylationLEGTEDLSDVLVRQG
CCCCCCHHHHHHHCC
37.6921406692

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
49TPhosphorylationKinaseCDK2P24941
PSP
570SPhosphorylationKinaseCSNK2A1P68400
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CND2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CND2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMC2_HUMANSMC2physical
21633354
CND1_HUMANNCAPD2physical
17268547
CND3_HUMANNCAPGphysical
17268547
SMC4_HUMANSMC4physical
17268547
SMC2_HUMANSMC2physical
17268547
CND3_HUMANNCAPGphysical
22939629
SMC2_HUMANSMC2physical
22939629
SMC4_HUMANSMC4physical
22939629
HECD3_HUMANHECTD3physical
22863883
LMNB1_HUMANLMNB1physical
22863883
ZZEF1_HUMANZZEF1physical
22863883
SMC2_HUMANSMC2physical
26344197
ALDOA_HUMANALDOAphysical
26496610
TERA_HUMANVCPphysical
26496610
CND1_HUMANNCAPD2physical
26496610
SMC4_HUMANSMC4physical
26496610
SCAM2_HUMANSCAMP2physical
26496610
SMC2_HUMANSMC2physical
26496610
HEXI1_HUMANHEXIM1physical
26496610
RB15B_HUMANRBM15Bphysical
26496610
HEAT3_HUMANHEATR3physical
26496610
MCAF1_HUMANATF7IPphysical
26496610
CND3_HUMANNCAPGphysical
26496610
CEP85_HUMANCEP85physical
26496610
KLC2_HUMANKLC2physical
26496610
S38AA_HUMANSLC38A10physical
26496610
SMC2_HUMANSMC2physical
26166704
SMC4_HUMANSMC4physical
26166704
CND1_HUMANNCAPD2physical
26166704
CND3_HUMANNCAPGphysical
26166704
HECD1_HUMANHECTD1physical
26166704
TBP_HUMANTBPphysical
26257282

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CND2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-637, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND THR-605, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-49; SER-70; SER-78;SER-81; SER-87; SER-92; SER-201; SER-432; THR-605 AND THR-614, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87; SER-201 AND SER-408,AND MASS SPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-49; SER-78; SER-81;SER-92; SER-96; SER-201; SER-335 AND THR-605, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-49, AND MASSSPECTROMETRY.

TOP